Nexalis Therapeutics Ltd Stock: price and insider trades · Australia

Nexalis Therapeutics Ltd belongs to the Health Care sector. Filings by its managers are published through ASX. Over the twelve months to 20 October 2026, 8 filings were filed, from 6 insiders.

Only sales appear on the open market, 2 sales in all, filed by 1 insider. The totals do not cover 2 filings with an undisclosed amount.

Half of the filings or more reach the ASX feed on the day of the trade. That lag is the time during which only the insider knows about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.

For context, the typical company on the same exchange (median of 1,587 companies) published 4 filings over the same period, against 8 filings here. Our records for Nexalis Therapeutics Ltd go back to 2026, with no purchases and 2 sales on the open market in total.

In the same sector, recent insider purchases at Vivos Inc and Anixa Biosciences Inc also feature in our signals. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.